News & Updates
Now available : Refreshed self-audit tools to advance radiotherapy quality improvement
2026-06-25
Great news for radiotherapy centres across Canada: CPQR self-audit tools are back! Since their launch in 2020, these tools have helped radiation treatment programs across Canada measure their alignment with nationally-validated quality indicators and drive meaningful program improvement.
Evidence Brief: “Scaling and Sustaining Cancer Control Innovations to Improve Access and Strengthening of Oncology Workforce: Pan-Canadian Considerations.”
2026-06-10
Innovation in cancer care cannot be considered independently of the workforce.
This was a key finding from Health Services & Policy Research examining innovations implemented in cancer care across Canada and internationally. These insights are highlighted in the evidence brief…
CPQR Annual Highlights 2025-26
2026-06-08
Since its creation in 2010, the Canadian Partnership for Quality Radiotherapy (CPQR) has made meaningful progress in advancing quality and safety in radiotherapy across Canada. Through close collaboration with provincial cancer agencies and programs, CPQR has developed pan-Canadian guidelines, led…
Now available: Emergency Preparedness Framework for Radiotherapy Centres
2026-06-04
Nobody wants to see the delivery of life-saving radiotherapy treatment disrupted, for any reason. Unfortunately, cyberattacks, environmental hazards and technical failures are among the numerous unplanned interruptions that can and do happen and can lead to prolonged downtime.
These disruptions…
2024-25 Annual Report, pan-Canadian Cancer Genomics Community of Practice
2025-12-16
The 2024-25 annual report from the Pan-Canadian Cancer Genomics Community of Practice showcases achievements throughout the year and details next steps toward equitable, standardized biomarker testing.
Recently published: Draft assessment framework for biomarkers used in cancer care
2025-11-17
Members of the Pan-Canadian Cancer Genomics Community of Practice contributed to the development of a consensus-based assessment framework to support the standardized, efficient, and transparent evaluation of molecular, genetic, and genomic biomarkers in cancer care in Canada.
